Other News To Note
Tuesday, October 18, 2011
Capstone Therapeutics, of Tempe, Ariz., is cutting 14 of its 18 full-time employees to preserve cash during ongoing discussions with potential partners for dermal scarring drug AZX100. The company has been struggling since Phase IIa trials fell short of statistical significance last year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.